Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Change in Acquisitions & Divestments (2016 - 2021)

Akebia Therapeutics (AKBA) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $20.0 million as the latest value for Q2 2021.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A to $20.0 million in Q2 2021 year-over-year; TTM through Mar 2022 was $20.0 million, a 75.0% decrease, with the full-year FY2021 number at $40.0 million, down 33.6% from a year prior.
  • Change in Acquisitions & Divestments was $20.0 million for Q2 2021 at Akebia Therapeutics, roughly flat from $20.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $172.1 million in Q3 2018 to a low of -$167.1 million in Q4 2018.
  • A 5-year average of $26.0 million and a median of $27.1 million in 2017 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: plummeted 420.53% in 2018, then skyrocketed 8063.27% in 2021.
  • Akebia Therapeutics' Change in Acquisitions & Divestments stood at $52.1 million in 2017, then tumbled by 420.53% to -$167.1 million in 2018, then surged by 113.47% to $22.5 million in 2019, then surged by 166.67% to $60.0 million in 2020, then plummeted by 66.67% to $20.0 million in 2021.
  • Per Business Quant, the three most recent readings for AKBA's Change in Acquisitions & Divestments are $20.0 million (Q2 2021), $20.0 million (Q1 2021), and $60.0 million (Q4 2020).